Skip to content

MDMA: all studies

Page 304 of 345: studies 3,031 to 3,040 of 3,446, newest first. Back to the MDMA overview

Research

Premier bilan des analyses toxicologiques effectuées dans le contexte du Drug Checking à Genève

December 1, 2020 Caroline Mathon, Christèle Widmer, R. Mégevand et al.

Objectif Depuis de nombreuses annees, la politique en matiere de drogues est basee en Suisse sur quatre piliers, a savoir la prevention, la therapie, la repression et la reduction des risques. Parmi les actions mises en œuvre concernant la reduction des risques lies aux consommations recreatives de substances psychoactives, une nouvelle offre a ete proposee depuis 2019 a Geneve, consistant en...

Ecstatic expeditions: Fischl Schneersohn's "science of man" between modern psychology and Jewish mysticism.

Transcultural Psychiatry December 1, 2020 David Freis 2 citations

This article examines Fischl Schneersohn's (1887-1958) "science of man" as a psychotherapeutic approach situated between modern psychology and Chassidic mysticism. While almost forgotten today, Schneersohn was a prolific writer, well-known in Yiddish-speaking circles as a psychologist, educationalist, novelist, and psychotherapist. As a descendant of an important dynasty of Chassidic rebbes, he...

Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats

Behavioural Pharmacology December 1, 2020 Keli A. Herr, Lisa E Baker 9 citations

Recent discoveries from clinical trials with psychedelic-assisted therapy have led to a resurgence of interest in the psychopharmacology of lysergic acid diethylamide (LSD). Preclinical drug discrimination is an invaluable tool to investigate the neurochemical mechanisms underlying subjective drug effects. The current study extends previous drug discrimination research by including both sexes....

Efavirenz as a psychotropic drug.

European review for medical and pharmacological sciences October 2020 N Zareifopoulos, M Lagadinou, A Karela et al.

Antiretroviral drugs are the mainstay of treatment for human immunodeficiency virus (HIV) infection. Lifelong highly active antiretroviral therapy (HAART) is indicated to prevent disease progression to acquired immunodeficiency syndrome (AIDS). Efavirenz was a first-line component of HAART across the world for many years. The purpose of this article is to review the psychotropic properties of...

Hallucinogens: Magic Mushrooms, Ayahuasca, Mescal Buttons, and Dr. Hofmann’s Problem Child

October 1, 2020 Jerrold C Winter

Abstract There are about 400,000 species of plants in this world. Only a small fraction, perhaps 100 in number, contain hallucinogenic chemicals. Nearly a century ago, Lewis Lewin, professor of pharmacology at the University of Berlin, in speaking of drugs he called phantasticants, said “The passionate desire which … leads man to flee from the monotony of daily life … has made him discover...

The Role of Psychedelics and Counseling in Mental Health Treatment

Journal of Mental Health Counseling October 1, 2020 Russ Curtis, Lisen C. Roberts, Elizabeth Graves et al. 28 citations

Psychedelics (i.e., ketamine, methylenedioxymethamphetamine, psilocybin) have been effectively used globally for centuries to treat mental health and addiction issues. However, in the 1950s–1970s, a number of factors, including misuse, abuse, and poorly conceptualized and conducted clinical trials, caused the Federal Drug Administration to classify most of the psychedelic substances as having...

Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists

Journal of Evolutionary Psychology September 21, 2020 Monnica T. Williams, Sara Reed, Jamilah R. George 62 citations

Abstract Psychedelic medicine is an emerging field of research and practice that examines the psychotherapeutic effects of substances classified as hallucinogens on the human mind, body, and spirit. Current research explores the safety and efficacy of these substances for mental health disorders including anxiety, depression, and posttraumatic stress disorder (PTSD). Although current studies...

DOI: 10.1556/2054.2020.00137 (opens in new tab) Full text (opens in new tab) Facilitator Psychotherapist Mental health Racialization +3

Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish

Brain Sciences August 25, 2020 Micaela Tirri, Luisa Ponzoni, Sabrine Bilel et al. 9 citations

The drastic increase in hallucinogenic compounds in illicit drug markets of new psychoactive substances (NPS) is a worldwide threat. Among these, 2, 5-dimetoxy-4-bromo-amphetamine (DOB) and paramethoxyamphetamine (PMA; marketed as “ecstasy”) are frequently purchased on the dark web and consumed for recreational purposes during rave/dance parties. In fact, these two substances seem to induce the...

Preliminary exploration of an altered state of consciousness: the hyperalert-hyperreal state.

ScholarWorks@UMassAmherst July 29, 2020 Anthony Edward D'aguanno

Beginning in the fall of 1969, I went through a number of experiences v/hich I can only term "extraordinary". These are notes taken shortly after the first incident: A state of hyperalertness . Occurred with one other person. It was experienced as an immersion into a fantastic flow of energy and a manner of perceiving which made the "meanings" of all perceptions secondary to the direct...

Leisure as immediate conscious experience: Foundations, evaluation, and extension of the theory of structured experiences

July 27, 2020 G. Ellis, Jingxian Jiang, P. Freeman et al.

Abstract The nature, causes, and effects of immediate conscious leisure experiences have long been central interests of scholars. Significant contributions to the field include Abraham Maslow’s studies of ecstasy and peak experience, Sigmund Koch’s descriptions of two forms of consciousness, John Neulinger’s classification of immediate conscious experiences based on their motivational contexts,...